Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death worldwide,
with region specific etiologies. Despite improvements made in the diagnosis of HCC, the …

Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, is the sixth
most common cancer worldwide and the third leading cause of cancer-related death. The …

Hepatocellular carcinoma (HCC), the sixth most common cancer worldwide, has an
incidence rate equal to mortality. Over 80% of HCC cases occur within a high‐risk …

Hepatocellular carcinoma (HCC) is the liver's most common primary malignancy, with over
half a million new cases diagnosed each year and being the fourth leading cause of cancer …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and
the cancer with the fastest increase in mortality in the United States, with more than 39,000 …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with a high
rate of morbidity and mortality. HCC affects approximately one million individuals annually …

With increased understanding of cancer biology, a multitude of pathological, genetic, and
molecular events that drive hepatocarcinogenesis, including angiogenesis, invasion, and …

Biomarkers for surveillance, diagnosis and prediction of prognosis in patients with
hepatocellular carcinoma (HCC) are currently not ready for introduction into clinical practice …

The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …

Hepatocellular carcinoma (HCC) is the fifth commonest malignancy worldwide and its
incidence is rising. Surgery, including transplantation, remains the only potentially curative …